Urology

• 

  Publication Venue For

  • Views of Normal Bladder Function Among Women Experiencing Lower Urinary Tract Symptoms..  150:103-109. 2021
  • EDITORIAL COMMENT..  148:313. 2021
  • Immune Expression in Children With Vesicoureteral Reflux: A Pilot Study..  148:254-259. 2021
  • Urinary Pubic Symphysis Fistula Leads to Histopathologic Osteomyelitis in Prostate Cancer Survivors..  148:297-301. 2021
  • Response to Letter to Editor: "Development and Validation of a Male Anterior Urethral Stricture Classification System"..  147:327-328. 2021
  • Prostate Cancer Foundation Hormone-Sensitive Prostate Cancer Biomarker Working Group Meeting Summary. 2020
  • Cadaveric Laboratory Simulation Training of Male Stress Urinary Incontinence Treatment Improves Trainee Knowledge and Confidence..  143:48-54. 2020
  • Development and Validation of A Male Anterior Urethral Stricture Classification System..  143:241-247. 2020
  • Letter to the Editor-Reply..  143:270. 2020
  • Extirpative Cultures Reveal Infectious Pubic Bone Osteomyelitis in Prostate Cancer Survivors With Urinary-Pubic Symphysis Fistulae (UPF)..  142:221-225. 2020
  • Associations Between Female Sex and Treatment Patterns and Outcomes for Muscle-invasive Bladder Cancer. 2020
  • Lichen Sclerosus: More Than Meets the Eye..  139:18-21. 2020
  • EDITORIAL COMMENT..  136:249. 2020
  • Acute Presentation of Previously Unrecognized Congenital Ureteropelvic Junction Obstruction 5 Weeks After Radical Retropubic Prostatectomy..  135:20-23. 2020
  • Initial Evaluation of a Novel Modulated Radiofrequency-based Bladder Denervation Device..  134:237-242. 2019
  • Randomized Controlled Trial to Assess the Impact of High Concentration Intraurethral Lidocaine on Urodynamic Voiding Parameters..  133:72-77. 2019
  • EDITORIAL COMMENT..  130:53. 2019
  • The Distribution of Post-Void Residual Volumes in People Seeking Care in the Symptoms of Lower Urinary Tract Dysfunction Network Observational Cohort Study With Comparison to Asymptomatic Populations..  130:22-28. 2019
  • A Novel Proteomics Approach to Identify Serum and Urinary Biomarkers and Pathways that Associate with Lower Urinary Tract Symptoms in Men and Women: Pilot Results of the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Study..  129:35-42. 2019
  • Parental Preferences for Vesicoureteral Reflux Treatment: A Crowd-sourced, Best-worst Scaling Study..  128:71-77. 2019
  • Perioperative Intravesical Chemotherapy for Patients WithNon-Muscle-invasive Bladder Cancer: Understanding the Extent of and Sources of Variation in Guideline-recommended Use..  124:107-112. 2019
  • Growing Teratoma Syndrome of Testicular Origin..  123:20-23. 2019
  • Relationship Between Central Obesity, General Obesity, Overactive Bladder Syndrome and Urinary Incontinence Among Male and Female Patients Seeking Care for Their Lower Urinary Tract Symptoms..  123:34-43. 2019
  • The Stability of Physician-Specific Episode Costs for Urologic Cancer Surgery: Implications for Urologists Under the Merit-Based Incentive Program..  123:114-119. 2019
  • A Case of Fatal Clostridial Necrotizing Fasciitis After Radical Prostatectomy..  122:28-31. 2018
  • Wilms Tumor After Orthotopic Liver Transplant in a Patient With Alagille Syndrome..  121:171-174. 2018
  • Abdominal Radiography With Digital Tomosynthesis: An Alternative to Computed Tomography for Identification of Urinary Calculi?.  120:56-61. 2018
  • Could Nonenhanced Computer Tomography Suffice as the Imaging Study of Choice for the Screening of Asymptomatic Microscopic Hematuria?.  120:36-41. 2018
  • Disproportionate Use of Inpatient Care by Older Adults With Kidney Stones..  120:103-108. 2018
  • Li-Fraumeni Syndrome-related Malignancies Involving the Genitourinary Tract: Review of a Single-institution Experience..  119:55-61. 2018
  • Association Between Early Confirmatory Testing and the Adoption of Active Surveillance for Men With Favorable-risk Prostate Cancer..  118:127-133. 2018
  • Author Reply..  116:191-192. 2018
  • Mechanism of Action of the Transobturator Sling for Post-Radical Prostatectomy Incontinence: A Multi-institutional Prospective Study Using Dynamic Magnetic Resonance Imaging..  116:185-192. 2018
  • Outcomes of Ureteroscopic Stone Treatment in Patients With Spinal Cord Injury..  116:41-46. 2018
  • Spina Bifida Health-care Guidelines for Men's Health..  116:218-226. 2018
  • The Urology Applicant: An Analysis of Contemporary Urology Residency Candidates..  115:51-58. 2018
  • Unmasking of Urinary-pubic Symphysis Fistula After Implantation of Artificial Urinary Sphincter in Prostate Cancer Survivors-User Beware..  114:202-206. 2018
  • Use of Routine Home Health Care and Deviations From an Uncomplicated Recovery Pathway After Radical Prostatectomy..  112:74-79. 2018
  • Episode-based Payment Variation for Urologic Cancer Surgery..  111:78-85. 2018
  • Short-term Complication Rates Following Anterior Urethroplasty: An Analysis of National Surgical Quality Improvement Program Data..  111:197-202. 2018
  • Multiple Reflex Pathways Contribute to Bladder Activation by Intraurethral Stimulation in Persons With Spinal Cord Injury..  109:210-215. 2017
  • Outcomes of Urethroplasty to Treat Urethral Strictures Arising From Artificial Urinary Sphincter Erosions and Rates of Subsequent Device Replacement..  107:239-245. 2017
  • Author Reply..  106:43-44. 2017
  • Determining Resident Sleep During and After Call With Commercial Sleep Monitoring Devices..  106:39-44. 2017
  • Editorial Comment..  106:37. 2017
  • Editorial Comment..  104:35. 2017
  • Variable Pulse Duration From a New Holmium:YAG Laser: The Effect on Stone Comminution, Fiber Tip Degradation, and Retropulsion in a Dusting Model..  103:47-51. 2017
  • Intentional Omission of Ureteral Stents During Robotic-assisted Intracorporeal Ureteroenteric Anastomosis: Is It Safe and Feasible?.  102:116-120. 2017
  • Risk Factors Associated With Recurrent Urinary Tract Infection in Neurogenic Bladders Managed by Clean Intermittent Catheterization..  102:213-218. 2017
  • A Nationwide Assessment of the Emergency Department Management of Acute Urinary Retention Due to Urethral Stricture..  100:79-83. 2017
  • Pubic Bone Resection Provides Objective Pain Control in the Prostate Cancer Survivor With Pubic Bone Osteomyelitis With an Associated Urinary Tract to Pubic Symphysis Fistula..  100:234-239. 2017
  • Editorial Comment..  99:9. 2017
  • Is the Economic Impact and Utilization of Imaging Studies for Pediatric Urolithiasis Across the United States Increasing?.  94:208-213. 2016
  • A Critical Evaluation of the Utility of Imaging After Urethroplasty for Bulbar Urethral Stricture Disease..  91:203-207. 2016
  • Racial Disparities in Partial Nephrectomy Persist Across Hospital Types: Results From a Population-based Cohort..  90:69-74. 2016
  • Trends in Sickle Cell Disease-related Priapism in U.S. Children's Hospitals..  89:118-122. 2016
  • Editorial Comment..  88:132-133. 2016
  • Quality of Acute Care for Patients With Urinary Stones in the United States..  86:914-921. 2015
  • Long-term Artificial Urinary Sphincter Outcomes Following a Prior Rectourethral Fistula Repair..  86:608-612. 2015
  • Editorial Comment..  86:222-223. 2015
  • Critical Analysis of Patient-reported Complaints and Complications After Urethroplasty for Bulbar Urethral Stricture Disease..  85:1489-1493. 2015
  • Pilot Study Evaluating a Rat Model of Radiation-induced Erectile Dysfunction Using an Image-guided Microirradiator..  85:1214.e1-1214.e6. 2015
  • Pubic symphysis osteomyelitis in the prostate cancer survivor: clinical presentation, evaluation, and management..  85:684-690. 2015
  • NADiA ProsVue prostate-specific antigen slope, CAPRA-S, and prostate cancer--specific survival after radical prostatectomy..  84:1427-1432. 2014
  • Scrotal and perineal sensory neuropathy after urethroplasty for bulbar urethral stricture disease: an evaluation of the incidence, timing, and resolution..  84:1511-1515. 2014
  • The management of bulbar urethral stricture disease before referral for definitive repair: have practice patterns changed?.  84:946-949. 2014
  • Editorial comment..  83:1193-1194. 2014
  • Digital tomosynthesis: a new technique for imaging nephrolithiasis. Specific organ doses and effective doses compared with renal stone protocol noncontrast computed tomography..  83:282-287. 2014
  • Urinary concentrations of aquaporin-1 and perilipin-2 in patients with renal cell carcinoma correlate with tumor size and stage but not grade..  83:256.e9-256.14. 2014
  • Building a medical neighborhood in the safety net: an innovative technology improves hematuria workups..  82:1277-1282. 2013
  • Effect of supine vs prone position on outcomes of percutaneous nephrolithotomy in staghorn calculi: results from the Clinical Research Office of the Endourology Society Study..  82:1240-1244. 2013
  • Urinary outcomes are significantly affected by nerve sparing quality during radical prostatectomy..  82:1348-1353. 2013
  • The UroLume stent revisited: the Duke experience..  82:933-936. 2013
  • Urologist attitudes toward end-of-life care..  82:48-52. 2013
  • Pregnancy after varicocelectomy: impact of postoperative motility and DFI..  81:760-766. 2013
  • Quality assessment of economic analyses in pediatric urology..  81:263-267. 2013
  • Simvastatin suppresses cyclophosphamide-induced changes in urodynamics and bladder inflammation..  81:209.e9-209.14. 2013
  • NADiA ProsVue prostate-specific antigen slope is an independent prognostic marker for identifying men at reduced risk of clinical recurrence of prostate cancer after radical prostatectomy..  80:1319-1325. 2012
  • Urinary diversion in patients with spinal cord injury in the United States..  80:1247-1251. 2012
  • Partial orchiectomy for bilateral synchronous testicular masses in a prepubescent boy: a case report..  80:1144-1146. 2012
  • A 66-year-old man with prostate-specific antigen recurrence and lung mass after radical prostatectomy..  80:247-249. 2012
  • Bilateral renal cell carcinoma in a child..  80:430-433. 2012
  • Prognostic factors and outcomes after definitive treatment of female urethral cancer: a population-based analysis..  80:374-381. 2012
  • Characteristics and outcomes of tumors arising from the distal nephron..  80:140-146. 2012
  • Long-term outcomes after primary failures of artificial urinary sphincter implantation..  79:922-928. 2012
  • The effect of noise-cancelling headphones or music on pain perception and anxiety in men undergoing transrectal prostate biopsy..  79:32-36. 2012
  • Management of primary squamous cell carcinoma at the mucocutaneous junction of an ileal conduit..  78:1229-1231. 2011
  • Outcomes of grafted bulbar urethroplasty in men with class II or III obesity..  78:1420-1423. 2011
  • Does a controversial topic affect the quality of urologic information on the Internet?.  78:1051-1056. 2011
  • Focusing on testosterone..  78:S476-S477. 2011
  • Indications and practice with androgen deprivation therapy..  78:S478-S481. 2011
  • New data, new paradigms for treating prostate cancer patients--VI: novel hormonal therapy approaches..  78:S494-S498. 2011
  • Targeting the androgen receptor--theory and practice..  78:S482-S484. 2011
  • Traditional approaches to androgen deprivation therapy..  78:S485-S493. 2011
  • Diagnosis, staging, and risk factors: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009..  78:S427-S434. 2011
  • Are stone protocol computed tomography scans mandatory for children with suspected urinary calculi?.  78:662-666. 2011
  • Contemporary use of nephron-sparing surgery for children with malignant renal tumors at freestanding children's hospitals..  78:422-426. 2011
  • Editorial comment..  77:1068. 2011
  • Editorial comment..  77:991. 2011
  • Editorial comment..  77:991-992. 2011
  • University of Michigan surgical experience with ureterolysis for retroperitoneal fibrosis: a comparison of laparoscopic and open surgical approaches..  77:339-343. 2011
  • Analysis of urinary function using validated instruments and uroflowmetry after primary and salvage prostate cryoablation..  76:1258-1265. 2010
  • Editorial comment. Acute lower urinary tract symptoms after prostate brachytherapy with cesium-131..  76. 2010
  • Editorial comment. Acute lower urinary tract symptoms after prostate brachytherapy with cesium-131..  76:1147. 2010
  • Prostate-specific antigen-based risk-adapted discontinuation of prostate cancer screening in elderly African American and Caucasian American men..  76:1058-1062. 2010
  • Adult template circumcision: a prospective, randomized, patient-blinded, comparative study evaluating the safety and efficacy of a novel circumcision device..  76:810-814. 2010
  • Editorial comment..  76:1001. 2010
  • Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma..  76:593-599. 2010
  • Role of vitamin D(3) as a sensitizer to cryoablation in a murine prostate cancer model: preliminary in vivo study..  76:764.e14-764.e20. 2010
  • Contemporary epidemiology and characterization of newborn males with prune belly syndrome..  76:44-48. 2010
  • Ketorolac is underutilized after ureteral reimplantation despite reduced hospital cost and reduced length of stay..  76:9-13. 2010
  • Predicting success in the endoscopic management of pediatric vesicoureteral reflux..  76:195-198. 2010
  • Editorial comment..  75:1416-1417. 2010
  • The preoperative use of erythropoietin stimulating proteins prior to radical prostatectomy is not associated with increased cardiovascular or thromboembolic morbidity or mortality..  75:1424-1428. 2010
  • Public survey and survival data do not support recommendations to discontinue prostate-specific antigen screening in men at age 75..  75:1122-1127. 2010
  • The COMPARE Registry: design and baseline patterns of care for men with biochemical failure after definitive treatment of localized prostate cancer..  75:623-629. 2010
  • Tumor size and endophytic growth pattern affect recurrence rates after laparoscopic renal cryoablation..  75:307-310. 2010
  • Tumor volume, tumor percentage involvement, or prostate volume: which is predictive of prostate-specific antigen recurrence?.  75:460-466. 2010
  • Changes in Gleason score grading and their effect in predicting outcome after radical prostatectomy..  74:1090-1093. 2009
  • Editorial comment..  74:750. 2009
  • Editorial comment..  74:755-756. 2009
  • Focal therapy for prostate cancer is a reasonable treatment option in properly selected patients..  74:726-730. 2009
  • Delayed prostate-specific antigen recurrence after radical prostatectomy: how to identify and what are their clinical outcomes?.  74:643-647. 2009
  • Effect of age and pathologic Gleason score on PSA recurrence: analysis of 2911 patients undergoing radical prostatectomy..  74:654-658. 2009
  • Nonoperative management of nonvascular grade IV blunt renal trauma in children: meta-analysis and systematic review..  74:579-582. 2009
  • Epidemiology of nephrolithiasis in personnel returning from Operation Iraqi Freedom..  74:56-60. 2009
  • Prevalence of erectile dysfunction in men screened for prostate cancer..  74:89-93. 2009
  • Single-center North American experience with wolf Piezolith 3000 in management of urinary calculi..  73:958-963. 2009
  • Weekend admission and treatment of patients with renal colic: a case of avoidable variation?.  73:720-724. 2009
  • Atorvastatin-induced hemorrhagic cystitis: a case report..  73:681.e5-681.e6. 2009
  • Sacral neuromodulation in children with dysfunctional elimination syndrome: description of incisionless first stage and second stage without fluoroscopy..  73:641-644. 2009
  • Effect of flexible cystoscopy on serum prostate-specific antigen values..  73:237-240. 2009
  • Recurrent malignant melanoma of the penis..  72:1185.e15-1185.e16. 2008
  • Significant discrepancies between diagnostic and pathologic Gleason sums in prostate cancer: the predictive role of age and prostate-specific antigen..  72:882-886. 2008
  • Urothelial sloughing with obstruction after laparoscopic cryoablation of small renal carcinoma in solitary kidney..  72:716.e1-716.e2. 2008
  • The University of Michigan experience with percutaneous nephrostolithotomy for urinary matrix calculi..  72:61-64. 2008
  • Can prostate-specific antigen and prostate-specific antigen velocity be used for prostate cancer screening in men older than 70 years?.  71:1020-1023. 2008
  • Seven years after laparoscopic radical nephrectomy: oncologic and renal functional outcomes..  71:1149-1154. 2008
  • Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic..  71:787-791. 2008
  • Urology residency and research: round table discussion and plea for innovation..  71:762-765. 2008
  • p53 protein expression status and recurrence in men treated with radiation and androgen suppression therapy for higher-risk prostate cancer: a prospective phase II Cancer and Leukemia Group B Study (CALGB 9682)..  71:933-937. 2008
  • Body composition and serum prostate-specific antigen: review and findings from Flint Men's Health Study..  71:554-560. 2008
  • Trainees do not negatively impact the institutional learning curve for robotic prostatectomy as characterized by operative time, estimated blood loss, and positive surgical margin rate..  71:597-601. 2008
  • Utility of dextranomer/hyaluronic acid injection in setting of bladder and ureteral anomalies..  71:435-438. 2008
  • Minimally invasive management of retroperitoneal fibrosis..  71:201-204. 2008
  • A single-institution comparison between radical perineal and radical retropubic prostatectomy on perioperative and pathological outcomes for obese men: an analysis of the Duke Prostate Center database..  70:1146-1151. 2007
  • Prostate cancer in the Baby Boomer generation: results from CaPSURE..  70:1162-1167. 2007
  • Prostate cancer laterality does not predict prostate-specific antigen recurrence after radical prostatectomy..  70:1141-1145. 2007
  • The role of partial nephrectomy for the management of sporadic renal angiomyolipoma..  70:1064-1068. 2007
  • Retrograde ureteral stents for extrinsic ureteral obstruction: nine years' experience at University of Michigan..  70:846-850. 2007
  • Progression of disease despite good endoscopic local control of upper tract urothelial carcinoma..  70:469-472. 2007
  • Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology..  70:117-121. 2007
  • Tumor location does not affect long-term renal function after partial nephrectomy..  69:1059-1063. 2007
  • Rectourethral fistula after combination radiotherapy for prostate cancer..  69:898-901. 2007
  • Ureteropelvic junction obliteration resulting in nephrectomy after radiofrequency ablation of small renal cell carcinoma..  69:982.e3-982.e5. 2007
  • Financial comparative analysis of minimally invasive surgery to open surgery for localized prostate cancer: a single-institution experience..  69:311-314. 2007
  • Multiple nephron-sparing procedures in solitary kidney with recurrent, metachronous, nonfamilial renal cell carcinoma..  68:1343.e1-1343.e3. 2006
  • Progression of renal tumors after laparoscopic radiofrequency ablation..  68:968-971. 2006
  • Impact of Parkinson's disease on continence after radical prostatectomy..  68:575-577. 2006
  • Outcomes of Gleason score 10 prostate carcinoma treated by radical prostatectomy..  68:604-608. 2006
  • Should function and bother be measured and reported separately for prostate cancer quality-of-life domains?.  68:599-603. 2006
  • Prostate-specific antigen-based serial screening may decrease prostate cancer-specific mortality..  68:342-347. 2006
  • Is there a role for a low-carbohydrate ketogenic diet in the management of prostate cancer?.  68:15-18. 2006
  • Use of prostate-specific antigen in the follow-up of patients with localized prostate cancer: results of a nationwide survey of urologists..  68:80-84. 2006
  • Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy..  67:1257-1261. 2006
  • Ovarian hyperstimulation causing ureteral obstruction in a pregnant woman..  67:1085.e5-1085.e6. 2006
  • Renal calculi presenting as hyperhidrosis in patient with spinal cord injury..  67:1084.e13-1084.e14. 2006
  • Use of Stone Cone minimizes stone migration during percutaneous nephrolithotomy..  67:1066-1068. 2006
  • Xanthine urolithiasis..  67:1084.e9-1084.11. 2006
  • Ureteroscopic laser papillotomy to treat papillary calcifications associated with chronic flank pain..  67:683-687. 2006
  • Ureteral endometriosis in patients after total abdominal hysterectomy: presentation and diagnosis: a case series..  67:622.e13-622.e15. 2006
  • Leiomyosarcoma of scrotum--case report and review of literature..  67:424.e13-424.e15. 2006
  • Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer..  67:349-353. 2006
  • Complications after percutaneous radiofrequency ablation of renal tumors..  66:1176-1180. 2005
  • Prostate-specific antigen versus prostate-specific antigen density as predictor of tumor volume, margin status, pathologic stage, and biochemical recurrence of prostate cancer..  66:1229-1233. 2005
  • Location and etiology of flexible and semirigid ureteroscope damage..  66:958-963. 2005
  • Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases..  66:1054-1059. 2005
  • Sacral neuromodulation for intractable urge incontinence: are there factors associated with cure?.  66:746-750. 2005
  • Application of fibrin glue to damaged bladder mucosa in a case of BK viral hemorrhagic cystitis..  66:641-643. 2005
  • Urorectal septum malformation sequence..  66:657. 2005
  • Effect of ureteral access sheath on stone-free rates in patients undergoing ureteroscopic management of renal calculi..  66:252-255. 2005
  • Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study..  66:386-391. 2005
  • Supplement use among men with prostate cancer..  66:161-166. 2005
  • Epididymo-orchitis and testicular abscess due to Nocardia asteroides complex..  65:591. 2005
  • Lymphangioleiomyomatosis presenting as bladder outlet obstruction..  65:589-590. 2005
  • Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy?.  65:332-336. 2005
  • Ureteroscopic management of renal calculi in anomalous kidneys..  65:265-269. 2005
  • Heroic measures may not always be justified in extensive urethral stricture due to lichen sclerosus (balanitis xerotica obliterans)..  64:565-568. 2004
  • Impact of race on survival in men with metastatic hormone-refractory prostate cancer..  64:212-217. 2004
  • Management of nephropleural fistula after supracostal percutaneous nephrolithotomy..  64:241-245. 2004
  • Cancer control after low-dose-rate prostate brachytherapy performed by a multidisciplinary team with no previous prostate brachytherapy experience..  63:1128-1131. 2004
  • Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen..  63:900-904. 2004
  • Cost comparison of radical retropubic and radical perineal prostatectomy: single institution experience..  63:746-750. 2004
  • Radical prostatectomy lowers plasma vascular endothelial growth factor levels in patients with prostate cancer..  63:327-332. 2004
  • Combination of low-dose flutamide and finasteride for PSA-only recurrent prostate cancer after primary therapy..  62:872-876. 2003
  • Ureteral reimplantation for inadvertent ureteral injury during radical perineal prostatectomy..  62:941. 2003
  • Prospective evaluation of pain medication requirements and recovery after radical perineal prostatectomy..  62:693-697. 2003
  • Serotonergic modulation of bladder afferent pathways..  62:10-15. 2003
  • Helical computed tomography for identification of crossing vessels in ureteropelvic junction obstruction-comparison with operative findings..  62:35-39. 2003
  • Liposarcoma presenting as an intraluminal ureteral mass..  61:1035. 2003
  • Biochemical profile of stone-forming patients with diabetes mellitus..  61:523-527. 2003
  • Clear cell adenocarcinoma in a female urethral diverticulum..  61:644. 2003
  • Intravesical liposome administration--a novel treatment for hyperactive bladder in the rat..  61:656-663. 2003
  • Intravesical protamine sulfate and potassium chloride as a model for bladder hyperactivity..  61:664-670. 2003
  • Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy..  61:607-611. 2003
  • Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the Center for Prostate Disease Research nomograms..  61:589-595. 2003
  • A structured literature review to determine the use of the American Society for Therapeutic Radiology and Oncology consensus definition of biochemical failure..  61:391-396. 2003
  • Aphallia with congenital urethrorectal fistula..  61:458-459. 2003
  • Management of small renal tumors with radiofrequency ablation..  61:23-29. 2003
  • Molecular genetics and histopathologic features of adult distal nephron tumors..  60:941-946. 2002
  • Effect of flaxseed supplementation on prostatic carcinoma in transgenic mice..  60:919-924. 2002
  • Improved prostate cancer-specific survival and other disease parameters: impact of prostate-specific antigen testing..  60:756-759. 2002
  • Techniques to maximize flexible ureteroscope longevity..  60:784-788. 2002
  • Overview consensus statement. Newer approaches to androgen deprivation therapy in prostate cancer..  60:1-6. 2002
  • Receptor tyrosine kinases as rational targets for prostate cancer treatment: platelet-derived growth factor receptor and imatinib mesylate..  60:115-121. 2002
  • The role of androgen deprivation therapy combined with prostate brachytherapy..  60:39-44. 2002
  • Ureteroscopic treatment of renal calculi in morbidly obese patients: a stone-matched comparison..  60:393-397. 2002
  • Salvage radiotherapy for rising or persistent PSA after radical prostatectomy..  60:281-287. 2002
  • Hypertonic saline-augmented radiofrequency ablation of the VX-2 tumor implanted in the rabbit kidney: a short-term survival pilot study..  60:170-175. 2002
  • In vitro comparison of standard ultrasound and pneumatic lithotrites with a new combination intracorporeal lithotripsy device..  60:28-32. 2002
  • Successful angioembolization of renal artery pseudoaneurysms after blunt abdominal trauma..  59:444. 2002
  • Adult testicular sarcoma: presentation, evaluation, and treatment..  59:294-295. 2002
  • Flexible ureteroscopy in conjunction with in situ lithotripsy for lower pole calculi..  58:859-863. 2001
  • Arterial pseudoaneurysm complicating endoscopic fulguration of upper urinary tract urothelial carcinoma..  58:799. 2001
  • Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy..  58:723-728. 2001
  • Use of serum creatinine to predict pathologic stage and recurrence among radical prostatectomy patients..  58:729-734. 2001
  • Plastibell template circumcision: a new technique..  58:603-604. 2001
  • Comparison of outcomes of ureteroscopy for ureteral calculi located above and below the pelvic brim..  58:351-356. 2001
  • Outcome of intracytoplasmic sperm injection in azoospermic patients: stressing the liaison between the urologist and reproductive medicine specialist..  58:69-75. 2001
  • Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features..  58:47-52. 2001
  • A reliable, nondestructive animal model for interstitial cystitis: intravesical low-dose protamine sulfate combined with physiological concentrations of potassium chloride..  57:112. 2001
  • Gene therapy of bladder pain with herpes simplex virus (HSV) vectors expressing preproenkephalin (PPE)..  57:116. 2001
  • Intravesical ultrapotent vanilloid receptor agonists: acute effects on animal models of bladder irritation..  57:111-112. 2001
  • Suppression of the tetrodotoxin-resistant sodium channel (PN3/SNS): a possible new treatment for bladder pain..  57:116-117. 2001
  • cDNA array of lipopolysaccharide-induced bladder gene expression..  57:117. 2001
  • cDNA expression arrays: the effects of lactacystin in lipopolysaccharide-induced cystitis..  57:114-115. 2001
  • How do urology residents manage personal finances?.  57:866-871. 2001
  • Prostate-specific antigen-enhanced testing and risk stratification for chemoprevention trials..  57:174-177. 2001
  • Routine placement of ureteral stents is unnecessary after ureteroscopy for urinary calculi..  57:639-643. 2001
  • Impact of urethral injury management on the treatment and outcome of concurrent pelvic fractures..  57:439-442. 2001
  • Activity of the herbal combination, PC-SPES, in the treatment of patients with androgen-independent prostate cancer..  57:122-126. 2001
  • Removal of a UroLume prostatic stent using the holmium laser..  57:166-167. 2001
  • Impact of socioeconomic status and race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system..  56:1016-1020. 2000
  • Nitinol stone retrieval-assisted ureteroscopic management of lower pole renal calculi..  56:935-939. 2000
  • Outcome in 104 pubovaginal slings using freeze-dried allograft fascia lata from a single tissue bank..  56:2-8. 2000
  • Prostate-specific antigen levels in young white and black men 20 to 45 years old..  56:812-816. 2000
  • Urinary tract erosions after synthetic pubovaginal slings: diagnosis and management strategy..  56:589-594. 2000
  • Microdialysis assessment of shock wave lithotripsy-induced renal injury..  56:364-368. 2000
  • Urethral polyp presenting in a male infant with hematuria and urinary retention..  54:921-922. 1999
  • Androgen deprivation therapy for prostate cancer results in significant loss of bone density..  54:607-611. 1999
  • Prostate cancer: demographic and behavioral correlates of stage at diagnosis among blacks and whites in North Carolina..  53:1194-1199. 1999
  • Assessment of stricture formation with the ureteral access sheath. 2003
  • Editorial Comment..  99:74. 2017
  • Editorial Comment..  93:66-67. 2016
  • Author Reply..  91:207. 2016
  • Editorial Comment..  91:201-202. 2016
  • Editorial Comment..  89:142-143. 2016
  • Editorial comment..  87:131-132. 2016
  • Editorial Comment..  86:788. 2015
  • Editorial comment..  85:1199. 2015
  • Editorial comment..  85:90. 2015
  • Reply: To PMID 25432832..  84:1433. 2014
  • Editorial comment..  84:1178-1179. 2014
  • Editorial comment..  84:195-196. 2014
  • Editorial comment..  80:1006. 2012
  • New data, new paradigms for treating patients with prostate cancer. Conclusion..  78:S499. 2011
  • New data, new paradigms for treating patients with prostate cancer: introduction..  78:S475. 2011
  • Editorial comment..  78:152-153. 2011
  • Editorial comment..  77:1152-1153. 2011
  • Editorial comment. Anticholinergics do not improve cure rate of alarm treatment of monosymptomatic nocturnal enuresis..  77:724-725. 2011
  • Editorial comment..  77:199. 2011
  • Editorial comment. Which patients with undetectable PSA levels 5 years after radical prostatectomy are still at risk of recurrence?--Implications for a risk-adapted follow-up strategy..  76:1205. 2010
  • Editorial comment..  76:727. 2010
  • Editorial comment..  76:687. 2010
  • Editorial comment..  76:13-14. 2010
  • Editorial comment..  75:445-446. 2010
  • Editorial comment..  74:1221. 2009
  • Editorial comment. The value of intensive medical management of distal ureteral calculi in an effort to facilitate spontaneous stone passage..  56:582-583. 2000
  • Ablation of renal tumors in a rabbit model with interstitial saline-augmented radiofrequency energy..  54:382-383. 1999
  • The Impact of Alternative Alkalinizing Agents on 24-Hour Urine Parameters. 2020
  • Prevention of wrong site surgery during upper tract endoscopy. 2012
  • The evolving role of chemotherapy in androgen-independent (hormone-refractory) prostate cancer. 2005